Thrombotargets and Instituto Biomar Sign Drug Discovery Collaboration
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Thrombotargets Corp and Instituto Biomar have announced the signature of a drug discovery collaboration agreement.
Under the terms of this agreement, Instituto Biomar will provide Thrombotargets Corp with its libraries of purified natural products and extracts collection for its High Throughput Screening of Pathway Activity (HTS-PA) in Thrombotargets’ technology.
Thrombotargets will seek to identify and optimize drug candidates for multiple targets that will be jointly developed by both companies.
